A Case of Metastatic Thymoma Responsive to Treatment With 177Lu-DOTATATE

Review Oncology

The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?

Liliana Montella et al.

Summary: Thymic epithelial tumors are rare and often associated with paraneoplastic syndromes. Treatment options include surgical resection, platinum-refractory therapies, and somatostatin analogs, but their exact role in thymic tumors remains unclear.

CANCERS (2022)

Add to Collection

Article Oncology

Correlation of Somatostatin Receptor 2 Expression, 68Ga-DOTATATE PET Scan and Octreotide Treatment in Thymic Epithelial Tumors

Anja C. Roden et al.

Summary: The expression of SSTR2 in neuroendocrine tumors and carcinomas plays a role in imaging studies and guiding therapy. In this study, SSTR2 expression in TET was correlated with 68Ga-DOTATATE PET/CT or 68Ga-DOTATATE PET/MR results and treatment outcome. The findings suggest that 68Ga-DOTATATE PET scans are useful in identifying TET patients who may be amenable to treatment with somatostatin analogues.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Review Oncology

Imaging Evaluation of Thymoma and Thymic Carcinoma

Chad D. Strange et al.

Summary: Imaging is crucial in the management of patients with thymoma and thymic carcinoma, providing information for diagnosis, staging, assessing treatment response, and detecting recurrent disease.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Review Oncology

Consensus on molecular imaging and theranostics in neuroendocrine neoplasms

Valentina Ambrosini et al.

Summary: Nuclear medicine plays a crucial role in managing neuroendocrine neoplasms, using techniques such as peptide receptor radionuclide therapy and positron emission tomography. Recommendations from the European Association of Nuclear Medicine provide valuable guidance for the diagnosis and treatment of NETs.

EUROPEAN JOURNAL OF CANCER (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems